North America Active Pharmaceutical Ingredients Market Overview

Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate: 5.8% (2024-2032)

Market Size in 2023: USD 74.1 Billion

Market Forecast in 2032: USD 123.1 Billion

The North American active pharmaceutical ingredients (API) market is experiencing growth in biologics, as pharmaceutical companies shift focus toward biologic drugs for treating complex diseases. According to the latest report by IMARC Group, the market size reached US$ 74.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 123.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032.

There is a noticeable rise in contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs), as companies seek cost-effective production solutions. The use of synthetic biology and gene-based therapies is increasing, driven by advancements in biotechnology. Additionally, the trend toward personalized medicine is fostering the development of small-batch, custom APIs. The region is also witnessing an increase in API manufacturing for generic drugs due to patent expirations of major medications, contributing to market expansion. Environmental sustainability in API production is gaining traction, with a focus on green chemistry practices.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/north-america-active-pharmaceutical-ingredients-market/requestsample

North America Active Pharmaceutical Ingredients Industry Trends and Drivers:

The North American active pharmaceutical ingredients (API) market is primarily driven by the growing prevalence of chronic diseases, including cancer, diabetes, and cardiovascular disorders, is increasing the demand for generic and innovative medications, fueling the need for APIs. The aging population in North America also plays a crucial role, as older adults require more medication for age-related conditions. Additionally, rising healthcare expenditures in the region support the development and production of high-quality APIs, as pharmaceutical companies invest in advanced research and development to meet growing therapeutic needs. Another significant driver is the shift toward biologics and biosimilars, which require highly specialized APIs. The increasing focus on precision medicine and targeted therapies further propels API demand, especially for customized and small-batch production. The expansion of the pharmaceutical manufacturing sector, including contract manufacturing organizations (CMOs), also contributes to market growth, as outsourcing API production becomes more common to reduce costs and improve efficiency. Moreover, favorable regulatory frameworks in North America, including support from the U.S. Food and Drug Administration (FDA), encourage the development and approval of new drugs, enhancing the demand for APIs. The rise in generic drug production, driven by patent expirations, is another factor contributing to North America active pharmaceutical ingredients market growth, as manufacturers ramp up production to meet consumer demand for cost-effective alternatives.

North America Active Pharmaceutical Ingredients Industry Segmentation:

The report has segmented the market into the following categories:

Market by Drug Type

• Innovative Active Pharmaceutical Ingredients
• Generic Active Pharmaceutical Ingredients

Market by Manufacturer Type

• Captive Manufacturers
• Merchant API Manufacturers
  • Innovative Merchant API Manufacturers
  • Generic Merchant API Manufacturers

Market by Synthesis Type

• Synthetic Active Pharmaceutical Ingredients
  • Innovative Synthetic APIs
  • Generic Synthetic APIs
• Biotech Active Pharmaceutical Ingredients

• Market by Drug Type
  • Innovative Biotech APIs
  • Biosimilars
• Market by Product Type
  • Monoclonal Antibodies
  • Vaccines
  • Cytokines
  • Others
• Market by Expression System Type
  • Mammalian Expression System
  • Microbial Expression System
  • Yeast Expression System
  • Others

Market by Therapeutic Application

• Oncology
• Cardiovascular and Respiratory
• Diabetes
• Central Nervous System Disorders
• Neurological Disorders
• Others

Key Regions Analyzed

• United States
• Canada
• Mexico

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Ask Our Expert & Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=1521&flag=C

Key highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: [email protected] 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145